Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Neuropathologic features associated with Alzheimer disease diagnosis: age matters.

Middleton LE, Grinberg LT, Miller B, Kawas C, Yaffe K.

Neurology. 2011 Nov 8;77(19):1737-44. doi: 10.1212/WNL.0b013e318236f0cf. Epub 2011 Oct 26.

2.

Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.

Berg L, McKeel DW Jr, Miller JP, Storandt M, Rubin EH, Morris JC, Baty J, Coats M, Norton J, Goate AM, Price JL, Gearing M, Mirra SS, Saunders AM.

Arch Neurol. 1998 Mar;55(3):326-35.

PMID:
9520006
3.

Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.

Rapp MA, Schnaider-Beeri M, Purohit DP, Perl DP, Haroutunian V, Sano M.

Am J Geriatr Psychiatry. 2008 Feb;16(2):168-74. doi: 10.1097/JGP.0b013e31816029ec.

PMID:
18239198
4.

Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center.

Honig LS, Kukull W, Mayeux R.

Neurology. 2005 Feb 8;64(3):494-500.

PMID:
15699381
5.

Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.

Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.

JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721.

PMID:
26302353
6.

Relation of NSAIDs to incident AD, change in cognitive function, and AD pathology.

Arvanitakis Z, Grodstein F, Bienias JL, Schneider JA, Wilson RS, Kelly JF, Evans DA, Bennett DA.

Neurology. 2008 Jun 3;70(23):2219-25. doi: 10.1212/01.wnl.0000313813.48505.86.

PMID:
18519870
7.

Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old.

Polvikoski TM, van Straaten EC, Barkhof F, Sulkava R, Aronen HJ, Niinistö L, Oinas M, Scheltens P, Erkinjuntti T, Kalaria RN.

Neurology. 2010 Dec 7;75(23):2071-8. doi: 10.1212/WNL.0b013e318200d6f9. Epub 2010 Nov 3.

8.

Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons.

Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, Schneider JA.

Neurology. 2015 Dec 1;85(22):1930-6. doi: 10.1212/WNL.0000000000002175. Epub 2015 Nov 4.

PMID:
26537052
9.

A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment.

Gifford KA, Liu D, Hohman TJ, Xu M, Han X, Romano RR 3rd, Fritzsche LR, Abel T, Jefferson AL.

PLoS One. 2015 Nov 5;10(11):e0141831. doi: 10.1371/journal.pone.0141831. eCollection 2015.

10.

Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.

Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, Abner EL, Markesbery WR.

J Neuropathol Exp Neurol. 2007 Dec;66(12):1136-46.

11.

Alzheimer disease pathology and longitudinal cognitive performance in the oldest-old with no dementia.

Balasubramanian AB, Kawas CH, Peltz CB, Brookmeyer R, Corrada MM.

Neurology. 2012 Aug 28;79(9):915-21. doi: 10.1212/WNL.0b013e318266fc77. Epub 2012 Aug 15.

12.

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.

Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS.

Neurology. 2005 Mar 8;64(5):834-41.

PMID:
15753419
13.

Neuropathologic basis of age-associated brain atrophy.

Erten-Lyons D, Dodge HH, Woltjer R, Silbert LC, Howieson DB, Kramer P, Kaye JA.

JAMA Neurol. 2013 May;70(5):616-22. doi: 10.1001/jamaneurol.2013.1957.

14.

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.

Price JL, McKeel DW Jr, Buckles VD, Roe CM, Xiong C, Grundman M, Hansen LA, Petersen RC, Parisi JE, Dickson DW, Smith CD, Davis DG, Schmitt FA, Markesbery WR, Kaye J, Kurlan R, Hulette C, Kurland BF, Higdon R, Kukull W, Morris JC.

Neurobiol Aging. 2009 Jul;30(7):1026-36. doi: 10.1016/j.neurobiolaging.2009.04.002. Epub 2009 Apr 18.

15.

Comparison of symptomatic and asymptomatic persons with Alzheimer disease neuropathology.

Monsell SE, Mock C, Roe CM, Ghoshal N, Morris JC, Cairns NJ, Kukull W.

Neurology. 2013 Jun 4;80(23):2121-9. doi: 10.1212/WNL.0b013e318295d7a1. Epub 2013 May 3.

16.

A 2-process model for neuropathology of Alzheimer's disease.

Mungas D, Tractenberg R, Schneider JA, Crane PK, Bennett DA.

Neurobiol Aging. 2014 Feb;35(2):301-8. doi: 10.1016/j.neurobiolaging.2013.08.007. Epub 2013 Sep 27.

17.

Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease.

Morris JC, Price JL.

J Mol Neurosci. 2001 Oct;17(2):101-18. Review.

PMID:
11816784
18.

The neuropathology of Alzheimer disease in African American and white individuals.

Wilkins CH, Grant EA, Schmitt SE, McKeel DW, Morris JC.

Arch Neurol. 2006 Jan;63(1):87-90.

PMID:
16401740
19.

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations.

Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C; Arizona Parkinson's Disease Consortium.

Parkinsonism Relat Disord. 2014 Sep;20(9):1009-14. doi: 10.1016/j.parkreldis.2014.06.018. Epub 2014 Jun 28.

20.

Sex differences in the clinical manifestations of Alzheimer disease pathology.

Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA.

Arch Gen Psychiatry. 2005 Jun;62(6):685-91.

PMID:
15939846
Items per page

Supplemental Content

Write to the Help Desk